Is UNII-24T2A1DOYB Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use UNII-24T2A1DOYB? Is UNII-24T2A1DOYB safe for nursing mother and child? Does UNII-24T2A1DOYB extracts into breast milk? Does UNII-24T2A1DOYB has any long term or short term side effects on infants? Can UNII-24T2A1DOYB influence milk supply or can UNII-24T2A1DOYB decrease milk supply in lactating mothers?
Answer by DrLact: About UNII-24T2A1DOYB usage in lactation
No information is available on the clinical use of UNII-24T2A1DOYB during breastfeeding. Because UNII-24T2A1DOYB is 99.5% bound to plasma proteins, the amount in milk is likely to be low. However, one of its metabolites has a half-life of up to 70 hours, and might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during UNII-24T2A1DOYB therapy and for 2 weeks after the final dose.
Alternate Drugs
Cetuximab(Unsafe)
Etoposide(Dangerous)
Bleomycin(Dangerous)
Imatinib(Unsafe)
Carboplatin(Dangerous)
Doxorubicin(Dangerous)
Vinorelbine(Dangerous)
Paclitaxel(Dangerous)
Cyclophosphamide(Dangerous)
Dacarbazine(Dangerous)
Azelaic Acid(Safe)
Dasatinib(Unsafe)
Fluorouracil(Dangerous)
Cisplatin(Unsafe)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Busulfan(Dangerous)
Docetaxel(Dangerous)
Rituximab(Low Risk)
Gemcitabine(Dangerous)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Vincristine(Dangerous)
Letrozole(Dangerous)
Tamoxifen(Dangerous)
Erlotinib(Unsafe)
Trastuzumab(Unsafe)
Exemestane(Dangerous)
Mitoxantrone(Dangerous)
Cladribine(Dangerous)
Mercaptopurine(Safe)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Hydroxyurea(Low Risk)
Vinblastine(Dangerous)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Gemcitabine(Dangerous)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Allopurinol(Safe)
Erlotinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)